Hero_Allevyn-Life.png

Other Wound Care Solutions

References

1. Joy H, Bielby A, Searle R. A collaborative project to enhance efficiency through dressing change practice. J Wound Care. 2015;24(7):312, 314 – 317.

2. Forni C, D’alessandro F, Gallerani P, et al. Effectiveness of using a new polyurethane foam multi-layer dressing in the sacral area to prevent the onset of pressure ulcer in the elderly with hip fractures: A pragmatic randomised controlled trial. Int Wound J. 2018;15(3):1 - 8.

3. Smith+Nephew 2012.Simulated Wound Model Testing of ALLEVYN Life and Mepilex Border. Internal Report. DS/12/130/DOF.

4. Rossington A, Drysdale K, Winter R. Clinical performance and positive impact on patient wellbeing of ALLEVYN Life. Wounds UK. 2013;9(4):91 - 95.

 5. Simon D, Biel A. A structured collaborative approach to appraise the clinical performance of a new product. Wounds UK. 2014;10(3):80 - 87.

6. Smith+Nephew 2016.New ALLEVYN Life Gen2 wcl - Physical Testing. Internal Report. DS/15/025/R.

7. Viamontes L, Jones AM. Evaluation study of the properties of two adhesive foam dressings. Br J Nurs (Tissue Viability Supplement). 2003;12(11):S43 - S49.

8.Stephen-Haynes J, Bielby A, Searle R. The clinical performance of a silicone foam in an NHS community trust. Journal of Community Nursing. 2013;27(5):50 - 59.

9. Smith+Nephew 2016.Wound Model Testing of New ALLEVYN Life Gen2 wcl Dressing using Horse Serum at a Flow Rate Modelling that of a Moderately Exuding Wound. DS/14/303/R.

10. Smith+Nephew 2016.Product Performance of Next Generation ALLEVYN Life Internal Report. (HVT080) GMCA-DOF/08.

11. Lisco C. Evaluation of a new silicone gel-adhesive hydrocellular foam dressing as part of a pressure ulcer prevention plan for ICU patients. Paper presented at: WOCN; 2013.

12. Clarke R. Positive patient outcomes: The use of a new silicone adhesive foam dressing for pressure ulcer prevention and treatment. Paper presented at: CAET; 2013.

13. Smith+Nephew 20 June 2016.A Randomised Cross-Over Clinical Evaluation to Compare Performance of ALLEVYN™ Life and Mepilex® Border Dressings on Patient Wellbeing-Related Endpoints. Internal Report. CE/047/ALF.

14. Smith+Nephew 14 June 2012.Odour reducing properties of ALLEVYN Life. Internal Report. DS/12/127/DOF.

15. Smith+Nephew 2018.Use of Moisture Vapour Permeability* (MVP) and Moisture Vapour Transmission Rate** (MVTR) data to support product claims referring to moist wound healing. Internal Report. EO.AWM.PCSgen.001.v2.

16. Smith+Nephew June 2016.Bacterial Barrier properties of New ALLEVYN™ LIFE Gen 2 WCL against Serratia marcescens. Internal Report. DOF 1606005

17.Smith+Nephew February 2016 2016.Subjective comparison of masking ability of the New ALLEVYN LIFE versus Current ALLEVYN LIFE by Healthcare Professionals. Internal Report. DS/16/061/R.

 

Title

Text